BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 35130915)

  • 1. Identification of targetable kinases in idiopathic pulmonary fibrosis.
    Higo H; Ohashi K; Tomida S; Okawa S; Yamamoto H; Sugimoto S; Senoo S; Makimoto G; Ninomiya K; Nakasuka T; Nishii K; Taniguchi A; Kubo T; Ichihara E; Hotta K; Miyahara N; Maeda Y; Toyooka S; Kiura K
    Respir Res; 2022 Feb; 23(1):20. PubMed ID: 35130915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis.
    Bartis D; Crowley LE; D'Souza VK; Borthwick L; Fisher AJ; Croft AP; Pongrácz JE; Thompson R; Langman G; Buckley CD; Thickett DR
    BMC Pulm Med; 2016 Apr; 16(1):51. PubMed ID: 27080864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses.
    Guyard A; Danel C; Théou-Anton N; Debray MP; Gibault L; Mordant P; Castier Y; Crestani B; Zalcman G; Blons H; Cazes A
    Respir Res; 2017 Jun; 18(1):120. PubMed ID: 28619094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic profiles of lung cancer associated with idiopathic pulmonary fibrosis.
    Hwang JA; Kim D; Chun SM; Bae S; Song JS; Kim MY; Koo HJ; Song JW; Kim WS; Lee JC; Kim HR; Choi CM; Jang SJ
    J Pathol; 2018 Jan; 244(1):25-35. PubMed ID: 28862766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.
    DePianto DJ; Chandriani S; Abbas AR; Jia G; N'Diaye EN; Caplazi P; Kauder SE; Biswas S; Karnik SK; Ha C; Modrusan Z; Matthay MA; Kukreja J; Collard HR; Egen JG; Wolters PJ; Arron JR
    Thorax; 2015 Jan; 70(1):48-56. PubMed ID: 25217476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paired genetic analysis by next-generation sequencing of lung cancer and associated idiopathic pulmonary fibrosis.
    Otsubo K; Iwama E; Ijichi K; Kubo N; Yoneshima Y; Inoue H; Tanaka K; Osoegawa A; Tagawa T; Nakanishi Y; Okamoto I
    Cancer Sci; 2020 Jul; 111(7):2482-2487. PubMed ID: 32426915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Potential Effects of Curcumin on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)-Approaching with Next-Generation Sequencing and Bioinformatics.
    Chang WA; Chen CM; Sheu CC; Liao SH; Hsu YL; Tsai MJ; Kuo PL
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33233354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of lung molecular signatures reveals key drivers of idiopathic pulmonary fibrosis.
    Kim SK; Jung SM; Park KS; Kim KJ
    BMC Pulm Med; 2021 Dec; 21(1):404. PubMed ID: 34876074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis.
    Vukmirovic M; Herazo-Maya JD; Blackmon J; Skodric-Trifunovic V; Jovanovic D; Pavlovic S; Stojsic J; Zeljkovic V; Yan X; Homer R; Stefanovic B; Kaminski N
    BMC Pulm Med; 2017 Jan; 17(1):15. PubMed ID: 28081703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomic profiling reveals disease-specific characteristics of epithelial cells in idiopathic pulmonary fibrosis.
    Boesch M; Baty F; Brutsche MH; Tamm M; Roux J; Knudsen L; Gazdhar A; Geiser T; Khan P; Hostettler KE
    Respir Res; 2020 Jun; 21(1):165. PubMed ID: 32605572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis.
    Li Y; He Y; Chen S; Wang Q; Yang Y; Shen D; Ma J; Wen Z; Ning S; Chen H
    Front Immunol; 2022; 13():810338. PubMed ID: 35185901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase D is increased and activated in lung epithelial cells and macrophages in idiopathic pulmonary fibrosis.
    Gan H; McKenzie R; Hao Q; Idell S; Tang H
    PLoS One; 2014; 9(7):e101983. PubMed ID: 25000413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL14 is a candidate biomarker for Hedgehog signalling in idiopathic pulmonary fibrosis.
    Jia G; Chandriani S; Abbas AR; DePianto DJ; N'Diaye EN; Yaylaoglu MB; Moore HM; Peng I; DeVoss J; Collard HR; Wolters PJ; Egen JG; Arron JR
    Thorax; 2017 Sep; 72(9):780-787. PubMed ID: 28250200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis.
    Aoshima Y; Enomoto Y; Muto S; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
    Lung; 2021 Jun; 199(3):289-298. PubMed ID: 33770226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of ADAR1 and ADAR2 in the Regulation of miRNA-21 in Idiopathic Pulmonary Fibrosis.
    Díaz-Piña G; Ordoñez-Razo RM; Montes E; Páramo I; Becerril C; Salgado A; Santibañez-Salgado JA; Maldonado M; Ruiz V
    Lung; 2018 Aug; 196(4):393-400. PubMed ID: 29637273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatic analysis of next‑generation sequencing data to identify dysregulated genes in fibroblasts of idiopathic pulmonary fibrosis.
    Sheu CC; Chang WA; Tsai MJ; Liao SH; Chong IW; Kuo PL
    Int J Mol Med; 2019 Apr; 43(4):1643-1656. PubMed ID: 30720061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.
    Allen RJ; Porte J; Braybrooke R; Flores C; Fingerlin TE; Oldham JM; Guillen-Guio B; Ma SF; Okamoto T; John AE; Obeidat M; Yang IV; Henry A; Hubbard RB; Navaratnam V; Saini G; Thompson N; Booth HL; Hart SP; Hill MR; Hirani N; Maher TM; McAnulty RJ; Millar AB; Molyneaux PL; Parfrey H; Rassl DM; Whyte MKB; Fahy WA; Marshall RP; Oballa E; Bossé Y; Nickle DC; Sin DD; Timens W; Shrine N; Sayers I; Hall IP; Noth I; Schwartz DA; Tobin MD; Wain LV; Jenkins RG
    Lancet Respir Med; 2017 Nov; 5(11):869-880. PubMed ID: 29066090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression analysis of Akt and MAPK signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (IPF).
    Antoniou KM; Margaritopoulos GA; Soufla G; Symvoulakis E; Vassalou E; Lymbouridou R; Samara KD; Kappou D; Spandidos DA; Siafakas NM
    J Recept Signal Transduct Res; 2010 Aug; 30(4):262-9. PubMed ID: 20536315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors.
    Korfei M; von der Beck D; Henneke I; Markart P; Ruppert C; Mahavadi P; Ghanim B; Klepetko W; Fink L; Meiners S; Krämer OH; Seeger W; Vancheri C; Guenther A
    J Proteomics; 2013 Jun; 85():109-28. PubMed ID: 23659799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle.
    Meltzer EB; Barry WT; D'Amico TA; Davis RD; Lin SS; Onaitis MW; Morrison LD; Sporn TA; Steele MP; Noble PW
    BMC Med Genomics; 2011 Oct; 4():70. PubMed ID: 21974901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.